Showing 1431-1440 of 3298 results for "".
Of Pandemics and Postponements
https://practicaldermatology.com/topics/practice-management/of-pandemics-and-postponements/23342/Music City SCALE Wrap-Up
https://practicaldermatology.com/conferences/scale-2024/music-city-scale-wrap/26555/Music City SCALE Wrap-UpBlinded by the Light—and More
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/blinded-by-the-lightand-more/23154/CSF faculty members share their favorite Energy- and Light-Based Devices.New in My Practice: OTC/New Products
https://practicaldermatology.com/columns/new-products/new-in-my-practice-otcnew-products-2/23654/Sneak Peek: CSF Returns to Nashville
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2021/sneak-peek-csf-returns-to-nashville/23617/Next month’s live meeting covers a range of hot topics in dermatology.CSF Faculty: Sunscreen Picks
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2021/csf-faculty-sunscreen-picks/23490/Hyperpigmentation Treatment Pearls and More
https://practicaldermatology.com/conferences/cosmetic-surgery-forum-2022/hyperpigmentation-treatment-pearls-and-more/20161/Corey Hartman, MD shares his approach to treating periorbital hyperpigmentation in darker skin types, including using fillers to replace volume, give lift, and replace loss of bony structures and fat pads. Dr. Hartman also discusses the benefits of Cynosure’s PicoSure device to correct hyperpigmentaDermWireTV: Incyte's Opzelura, BMS Patient Week, Science of Skincare Summit
https://practicaldermatology.com/topics/psoriasis/dermwiretv-incytes-opzelura-bms-patient-week-science-of-skincare-summit/20003/Incyte’s Opzelura is the first topical JAK inhibitor approved in the US. Lawrence Eichenfield, MD weighs in on the cream formulation of ruxolitinib for treatment of mild-to-moderate atopic dermatitis in non-immunocompromised patients 12 years of age and older. Bristol Myers Squibb's seventh Global PSkin Reactions: Understanding New Drug Adverse Effects
https://practicaldermatology.com/conferences/aad-summer-2021/skin-reactions-understanding-new-drug-adverse-effects/19975/In addition to needing to stay abreast of new drugs in dermatology, it's important for dermatologists to stay informed about new medications that come to market in general. Vinod Nambudiri, MD, MBA says there are often dermatology-related adverse events that need to be managed. He discusses new cancUpdates on AD Therapeutics
https://practicaldermatology.com/topics/atopic-dermatitis/updates-on-ad-therapeutics/19760/It's a "super-exciting" time in the world of atopic dermatitis because of a number of new developments happening very rapidly, shares Peter Lio, MD. Recent approvals and additional indications for treatments like dupilumab and crisaborole in pediatric populations have been welcome additions. And the